Atlas Trials

A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment

Clinical trial NCT02709382 · COMPLETED

Trial details

NCT number
NCT02709382
Sponsor
Wockhardt
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2016-03-01
Primary completion
2016-08-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.